• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际头痛学会全球偏头痛急性药物治疗实践推荐

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.

机构信息

Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

出版信息

Cephalalgia. 2024 Aug;44(8):3331024241252666. doi: 10.1177/03331024241252666.

DOI:10.1177/03331024241252666
PMID:39133176
Abstract

BACKGROUND

In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to provide treatment options for all possible settings, including those with limited access to migraine medications.

METHODS

An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group.

RESULTS

A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained.

CONCLUSION

Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.

摘要

背景

为了改善全球范围内偏头痛的管理,国际头痛学会(IHS)制定了一系列关于偏头痛急性药物治疗的实用建议。这些建议分为最佳和必要两类,以提供各种可能情况下的治疗选择,包括那些获得偏头痛药物有限的情况。

方法

一个 IHS 指导委员会根据偏头痛管理中的实际问题制定了一系列临床问题清单。一组选定的国际资深和初级头痛专家根据专家共识以及对现有国家和国际头痛指南和指导文件的审查制定了这些建议。在最初的搜索之后,工作组创建并审查了一份包含二十一份国家和国际指南的参考书目。

结果

共概述了十七个关于急性偏头痛治疗不同方面的问题。对于每一个问题,我们提供了一个最佳推荐,尽可能使用;以及一个必要推荐,在无法达到最佳水平时使用。

结论

即使在药物选择仍然有限的情况下,采用这些国际建议将改善全球范围内急性偏头痛治疗的质量。

相似文献

1
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.国际头痛学会全球偏头痛急性药物治疗实践推荐
Cephalalgia. 2024 Aug;44(8):3331024241252666. doi: 10.1177/03331024241252666.
2
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society.偏头痛和紧张型头痛药物的全球可及性:国际头痛学会的调查。
Cephalalgia. 2024 Nov;44(11):3331024241297688. doi: 10.1177/03331024241297688.
3
Are the current IHS guidelines for migraine drug trials being followed?当前国际头痛协会(IHS)关于偏头痛药物试验的指南是否得到遵循?
J Headache Pain. 2010 Dec;11(6):457-68. doi: 10.1007/s10194-010-0257-5. Epub 2010 Oct 8.
4
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.遵循 2008 年 IHS 成人慢性偏头痛预防性治疗药物对照试验指南。
Cephalalgia. 2019 Jul;39(8):1058-1066. doi: 10.1177/0333102419847751. Epub 2019 May 1.
5
American Headache Society members' assessment of headache diagnostic criteria.美国头痛协会成员对头痛诊断标准的评估。
Headache. 2003 Jan;43(1):2-13. doi: 10.1046/j.1526-4610.2003.03002.x.
6
The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies.2023 年急诊科成人偏头痛急性治疗更新方案:美国头痛学会对静脉内药物治疗的证据评估。
Headache. 2024 Jul-Aug;64(7):869-872. doi: 10.1111/head.14744. Epub 2024 Jun 3.
7
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.临床实践中偏头痛的诊断与管理指南。加拿大头痛协会。
CMAJ. 1997 May 1;156(9):1273-87.
8
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.国际头痛学会关于偏头痛治疗用神经调控设备临床试验的指南。
Cephalalgia. 2021 Oct;41(11-12):1135-1151. doi: 10.1177/03331024211010413. Epub 2021 May 14.
9
Evidence-based guidelines for the pharmacological treatment of migraine.偏头痛药物治疗的循证指南
Cephalalgia. 2025 Apr;45(4):3331024241305381. doi: 10.1177/03331024241305381. Epub 2025 Apr 25.
10
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine.国际头痛协会偏头痛预防性药物治疗全球实践建议
Cephalalgia. 2024 Sep;44(9):3331024241269735. doi: 10.1177/03331024241269735.

引用本文的文献

1
Ultrasound-guided block of the superior cervical ganglion for migraine attacks: a propensity score-matched retrospective study.超声引导下颈上神经节阻滞治疗偏头痛发作:一项倾向评分匹配的回顾性研究。
Front Pain Res (Lausanne). 2025 Aug 28;6:1556654. doi: 10.3389/fpain.2025.1556654. eCollection 2025.
2
The epidemiology, management, and the associated burden of migraine in Australian primary care: a retrospective analysis of electronic health record data.澳大利亚初级医疗中偏头痛的流行病学、管理及相关负担:电子健康记录数据的回顾性分析
J Headache Pain. 2025 Aug 19;26(1):186. doi: 10.1186/s10194-025-02103-2.
3
Therapeutic Management of Vestibular Disorders During Pregnancy: A Narrative and Evidence-Based Review.
孕期前庭疾病的治疗管理:一篇叙述性和循证综述
Cureus. 2025 Aug 9;17(8):e89705. doi: 10.7759/cureus.89705. eCollection 2025 Aug.
4
Headache Management in Military Primary Care: Findings from a Nationwide Cross-Sectional Study.军事初级保健中的头痛管理:一项全国性横断面研究的结果
J Clin Med. 2025 Jun 25;14(13):4497. doi: 10.3390/jcm14134497.
5
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand.泰国偏头痛急性和预防性治疗用 gepants 的专家共识。
J Headache Pain. 2025 Jun 2;26(1):131. doi: 10.1186/s10194-025-02074-4.
6
Pediatric migraine care: bridging gaps, overcoming barriers, and advancing solutions.儿童偏头痛护理:弥合差距、克服障碍并推进解决方案。
Eur J Pediatr. 2025 May 24;184(6):362. doi: 10.1007/s00431-025-06199-1.
7
Calcitonin gene-related peptide-targeted therapies for migraine.降钙素基因相关肽靶向治疗偏头痛
Aust Prescr. 2025 Apr;48(2):40-46. doi: 10.18773/austprescr.2025.017.
8
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment.头对头疗效对比:ubrogepant、rimegepant和zavegepant在偏头痛治疗中的应用
Pain Manag. 2025 May;15(5):279-284. doi: 10.1080/17581869.2025.2494494. Epub 2025 Apr 16.
9
Differences in pharmacological migraine treatment across different levels of clinical headache care - a cross-sectional study.不同临床头痛护理水平下偏头痛药物治疗的差异——一项横断面研究
J Headache Pain. 2025 Apr 14;26(1):78. doi: 10.1186/s10194-025-02027-x.
10
Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for Treatment.绝经、围绝经期与偏头痛:理解其交集及对治疗的影响
Neurol Ther. 2025 Jun;14(3):665-680. doi: 10.1007/s40120-025-00720-2. Epub 2025 Mar 14.